This webinar describes how human cells, tissues, or cellular and tissue-based products (HCT/Ps) are regulated under 21 CFR 1271. It discusses the origins of Good Tissue Practices (GTPs), the challenges in industrial cell therapy product development, the academic context of cell therapies, and the misconceptions and pitfalls in HCT/P classification. The webinar also includes an explanation of donor eligibility and safety considerations in HCT/Ps.
Release Date: May 14, 2026
Language Availability: English
Suggested Audiences: Academic Medical Centers, Biomedical Product Companies, Blood and Tissue Banks, Faculty, Principal Investigators, Sponsors, Students
Organizational Subscription Price: Included as part of an annual subscription to our All Access Webinar Package
Independent Learner Price: $49 per person
